Liu Zheng

Liu Zheng (born August 1954) is a retired lieutenant general in the People's Liberation Army of China. He served as Deputy Head of the PLA General Logistics Department. In November 2014 he was placed under investigation by the PLA's anti-corruption agency.

Liu was a member of the 12th National People's Congress. Provided by Wikipedia
Showing 461 - 464 results of 464 for search 'Zheng, Liu', query time: 0.03s Refine Results
  1. 461
    Engineering grain boundaries at the 2D limit for the hydrogen evolution reaction

    Engineering grain boundaries at the 2D limit for the hydrogen evolution reaction by Yongmin He, Pengyi Tang, Zhili Hu, Qiyuan He, Chao Zhu, Luqing Wang, Qingsheng Zeng, Prafful Golani, Guanhui Gao, Wei Fu, Zhiqi Huang, Caitian Gao, Juan Xia, Xingli Wang, Xuewen Wang, Chao Zhu, Quentin M. Ramasse, Ao Zhang, Boxing An, Yongzhe Zhang, Sara Martí-Sánchez, Joan Ramon Morante, Liang Wang, Beng Kang Tay, Boris I. Yakobson, Achim Trampert, Hua Zhang, Minghong Wu, Qi Jie Wang, Jordi Arbiol, Zheng Liu

    Published 2020-01-01
    Get full text
    Article
  2. 462
    Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants

    Identification of a highly conserved neutralizing epitope within the RBD region of diverse SARS-CoV-2 variants by Yanqun Wang, An Yan, Deyong Song, Maoqin Duan, Chuangchuang Dong, Jiantao Chen, Zihe Jiang, Yuanzhu Gao, Muding Rao, Jianxia Feng, Zhaoyong Zhang, Ruxi Qi, Xiaomin Ma, Hong Liu, Beibei Yu, Qiaoping Wang, Mengqi Zong, Jie Jiao, Pingping Xing, Rongrong Pan, Dan Li, Juxue Xiao, Junbo Sun, Ying Li, Linfeng Zhang, Zhenduo Shen, Baiping Sun, Yanyan Zhao, Lu Zhang, Jun Dai, Jingxian Zhao, Lan Wang, Changlin Dou, Zheng Liu, Jincun Zhao

    Published 2024-01-01
    Get full text
    Article
  3. 463
    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013

    A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013 by Foluso O. Ademuyiwa, Feng Gao, Cherease R. Street, Ina Chen, Donald W. Northfelt, Robert Wesolowski, Mili Arora, Adam Brufsky, E. Claire Dees, Cesar A. Santa-Maria, Roisin M. Connolly, Jeremy Force, Alvaro Moreno-Aspitia, John M. Herndon, Madelyn Carmody, Sherri R. Davies, Sarah Larson, Kathleen L. Pfaff, Stephanie M. Jones, Jason L. Weirather, Anita Giobbie-Hurder, Scott J. Rodig, Zheng Liu, Ian S. Hagemann, Elad Sharon, William E. Gillanders

    Published 2022-12-01
    Get full text
    Article
  4. 464
    Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5

    Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5 by Yanqun Wang, An Yan, Deyong Song, Chuangchuang Dong, Muding Rao, Yuanzhu Gao, Ruxi Qi, Xiaomin Ma, Qiaoping Wang, Hongguang Xu, Hong Liu, Jing Han, Maoqin Duan, Shuo Liu, Xiaoping Yu, Mengqi Zong, Jianxia Feng, Jie Jiao, Huimin Zhang, Min Li, Beibei Yu, Yanxia Wang, Fanhao Meng, Xiaodan Ni, Ying Li, Zhenduo Shen, Baiping Sun, Xin Shao, Haifeng Zhao, Yanyan Zhao, Rui Li, Yanan Zhang, Guangying Du, Jun Lu, Chunna You, Hua Jiang, Lu Zhang, Lan Wang, Changlin Dou, Zheng Liu, Jincun Zhao

    Published 2023-01-01
    Get full text
    Article

Search Tools: